Skip to main content

Table 1 Optimized mass parameters for analytes and internal standards

From: A LC–MS/MS method with column coupling technique for simultaneous estimation of lamivudine, zidovudine, and nevirapine in human plasma

Analyte/IS

Dwell time (ms)

Declustering potential (DP) (V)

Entrance potential (EP) (V)

Collision energy (CE) (V)

Collision cell exit potential (CXP) (V)

Collision activated dissociation (CAD) (psi)

Ion source voltage (V)

Curtain gas flow (CUR) (psi)

Lamivudine

400

30

10

20

12

08

5500

30

Lamivudine IS

400

30

10

20

12

08

5500

30

Zidovudine

400

20

10

17

07

08

5500

30

Zidovudine IS

400

35

10

13

07

08

5500

30

Nevirapine

400

40

10

35

12

08

5500

30

Nevirapine IS

400

40

10

35

17

08

5500

30